Real World Outcomes of CAR T-Cell Therapy for B-Cell Lymphoma in Adults Age ≥ 65: A Referral Center Experience
Andrew Vegel(University of Iowa Hospitals and Clinics), Kittika Poonsombudlert(University of Iowa Health Care), Hira Shaikh(University of Iowa Hospitals and Clinics), Margarida Magalhaes‐Silverman(University of Iowa Hospitals and Clinics), James McCollough(University of Iowa Hospitals and Clinics), Sarah L. Mott(University of Iowa), Christopher Strouse(University of Iowa Hospitals and Clinics)
Cited by 1
Related Papers
Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma
|Journal of Surgical Oncology|2014|274
Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study
|BJOG An International Journal of Obstetrics & Gynaecology|1995|215
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
|The Journal of Urology|2019|190
Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer
|JAMA Network Open|2023|117
Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer
|Cancer Research|2015|111